1974P A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder

Autor: DeCastro, G.J., Stein, M., Abate-Shen, C., Miles, C., Gray, J., Joffe, B., Anderson, C., Lenis, A., McKiernan, J.M.M.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S1143-S1143
Databáze: ScienceDirect